Free tool
FAERS Monitor: Lotronex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021107 or its brand name (Lotronex, Alosetron Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
833
Serious
362
43% of reports
Hospitalization
189
Death reported
41
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- constipation128
- drug ineffective125
- abdominal pain107
- diarrhoea107
- colitis ischaemic65
- vomiting56
- nausea54
- adverse event43
- abdominal pain upper38
- gastrointestinal injury35
- rectal haemorrhage35
- pain27
- weight decreased25
- death23
- headache23
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 182 |
| 2005 | 89 |
| 2006 | 112 |
| 2007 | 49 |
| 2008 | 23 |
| 2009 | 17 |
| 2010 | 23 |
| 2011 | 17 |
| 2012 | 31 |
| 2013 | 17 |
| 2014 | 17 |
| 2015 | 31 |
| 2016 | 37 |
| 2017 | 58 |
| 2018 | 27 |
| 2019 | 12 |
| 2020 | 16 |
| 2021 | 20 |
| 2022 | 18 |
| 2023 | 10 |
| 2024 | 7 |
| 2025 | 15 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,326 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| gastrointestinal injurySignal | 35 | 332.9 | 240.2 | 11,108 |
| colitis ischaemicSignal | 65 | 245.6 | 194.3 | 15,448 |
| rectal haemorrhageSignal | 35 | 20.6 | 14.9 | 634 |
| constipationSignal | 128 | 14.8 | 12.6 | 1,653 |
| adverse eventSignal | 43 | 11.8 | 8.8 | 415 |
| abdominal painSignal | 107 | 11.6 | 9.7 | 1,039 |
| abdominal pain upperSignal | 38 | 4.7 | 3.4 | 107 |
| diarrhoeaSignal | 107 | 4.2 | 3.5 | 264 |
| vomitingSignal | 56 | 3.0 | 2.3 | 75 |
| drug ineffectiveSignal | 125 | 2.4 | 2.0 | 107 |
| weight decreasedSignal | 25 | 2.3 | 1.5 | 17 |
| nausea | 54 | 1.7 | 1.3 | 16 |
| pain | 27 | 1.1 | 0.8 | 0 |
| headache | 23 | 0.9 | 0.6 | 0 |
| death | 23 | 0.7 | 0.5 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.